NCT03034642View on ClinicalTrials.gov

Modulation of Steroid Immunosuppression by Alveolar Efferocytosis

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 1, 2015

Primary Completion Date

March 20, 2020

Study Completion Date

December 30, 2021

Conditions
Pulmonary Disease, Chronic ObstructivePneumonia, Bacterial
Interventions
PROCEDURE

Bronchoscopy with bilateral bronchoalveolar lavages

Bronchoscopy with bilateral bronchoalveolar lavages

Trial Locations (1)

48105

VA Ann Arbor Healthcare System, Ann Arbor

All Listed Sponsors
collaborator

University of Michigan

OTHER

lead

VA Ann Arbor Healthcare System

FED

NCT03034642 - Modulation of Steroid Immunosuppression by Alveolar Efferocytosis | Biotech Hunter | Biotech Hunter